about

doctor attending conference

Know

Dr. Viraj Lavingia

Dr. Viraj Lavingia stands as a prominent figure in the landscape of Indian oncology, particularly renowned for his expertise and leadership in gastrointestinal (GI) cancers. His career trajectory, marked by significant academic contributions, pioneering clinical research, and dedicated patient care, paints a picture of a physician-scientist committed to advancing cancer treatment standards in India and beyond.

Currently serving as the Director of Oncosciences at the Shalby Group of Hospitals, Ahmedabad, Dr. Lavingia embodies the fusion of clinical excellence, research innovation, and administrative acumen. With around 10+ Years of Experience in GI Oncology, he has so far handled more than 5000 cases.

Dr. Viraj is

Foundation of Expertise | Education and Early Career

Dr. Lavingia is a trained and certified member of the European Society for Medical Oncology and the American Society of Clinical Oncology. During his fellowship, he demonstrated early leadership, managing teams, supervising junior doctors, handling complex inpatient and outpatient cases, managing emergencies, and actively participating in crucial multidisciplinary team (MDT) meetings, particularly for GI malignancies like colorectal cancer (CRC). His early career included significant roles at prestigious institutions like Lilavati Hospital and Fortis in Mumbai, and Apollo CBCC in Ahmedabad, building a robust clinical foundation before stepping into more specialized and leadership positions.

Education and Training

Doctor pic

Dr. Viraj's

Clinical and Research Prowess: Focus on GI Cancers

Dr. Lavingia’s core strength lies in his deep specialization in Gastrointestinal Oncology. His research output is prolific and impactful, consistently contributing to the evolving understanding and management of complex GI cancers. His publication record in esteemed journals like the South Asian Journal of Cancer (SAJC), Journal of Global Oncology (JGO), HPB, and Frontiers in Oncology demonstrates a focus on areas critical to the Indian and global context:

IMG-20230430-WA0006 (1)

His research is not confined to publications. Dr. Lavingia is actively involved in multicentric collaborative studies, most notably as a contributor to the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP), generating vital real-world data on outcomes and treatment patterns for these challenging cancers in India.

Dr. Viraj

A Visionary Force in Indian Oncology

Dr. Lavingia’s leadership extends beyond clinical practice into shaping the oncology community. As Director of Oncosciences at Shalby Hospitals, and previously as Director of GI Medical Oncology and Admin Head at HCG Cancer Centre, Ahmedabad, he has driven departmental growth and scientific excellence. A testament to his leadership is the successful conception and execution of the 1st SCRI-CON conference (July 2024), a pan-India Shalby initiative involving over 150 faculty members. He has also been the driving force behind a dedicated GI oncology conference since 2018, successfully navigating the pandemic with virtual editions and hosting over 200 national faculties for the 5th edition in 2022.

His commitment to nurturing the next generation is evident as a DNB Medical Oncology guide since 2018, having supervised 8 accepted theses and currently mentoring two more students. He actively disseminates knowledge through numerous invited lectures and seminars at national scientific meetings and has represented India internationally, including an invited talk at a SAARC meeting in Nepal (2019). His contributions to academia are further solidified by his role as an Associate Editor for GI Cancers with the International Journal of Molecular and Immuno Oncology (IJMPO).

Dr. Viraj's

Pioneering Clinical Trials and Global Engagement

Dr. Lavingia is at the forefront of bringing novel therapies to patients in India through active participation in clinical research. His role as a Principal Investigator (PI) or Co-PI spans numerous significant trials:

Late-Phase Trials

Including CORAL (NCT03564938), EMERALD-3 (NCT05301842), DRL Nivolumab (CTRI/2024/04/066248), Lupin Nivolumab (CTRI/2025/03/083471), T-DM1 biosimilar (CTRI/2024/08/072580), and CLARITY (NCT06346392).

Early-Phase Innovation

Demonstrating a commitment to cutting-edge drug development, he serves as Site PI for *multiple first-in-human Phase 1a studies* (Lupin’s LNP7457, LNP3693, LNP8701, and AUR103 in Gastric Cancer – CTRI/2025/03/081909).

His expertise is recognized internationally. He was a UICC (ICRETT) Fellow at the City of Hope, USA (2016), working under Dr. Marwan Fakih on hepatic arterial infusion chemotherapy. He holds certifications from ESMO (2015) and performed well in the ASCO in-training examination (2015). He actively presents real-world data at premier global conferences like ESMO and ASCO and participates in international advisory board meetings for pharmaceutical and diagnostic companies, contributing a valuable Indian perspective to global oncology strategies.

Recognition and Professional Standing

Dr. Lavingia’s achievements have been recognized through awards like the *ISMPO medal exam (2nd rank, 2017)* and the *scholarship for his UICC fellowship. He maintains active memberships in prestigious international and national oncology societies, including ASCO, ESMO, NANETS, IHPBA, INASL, and ISMPO, reflecting his standing within the global oncology community.

Dr. Viraj

A Visionary Force in Indian Oncology

Dr. Viraj Lavingia represents the pinnacle of dedication in the fight against Gastrointestinal Cancers in India. His unique blend of deep clinical expertise, prolific research output, visionary leadership, and commitment to education and clinical trials positions him as a true leader. He not only delivers exceptional patient care but also actively shapes the future of oncology practice through guidelines, research, and mentorship. As Director of Oncosciences at Shalby Hospitals, he continues to drive innovation and excellence, ensuring patients have access to the latest advancements and the highest standards of compassionate, evidence-based cancer care. Dr. Lavingia is not just a practitioner; he is a pivotal force propelling Indian gastrointestinal oncology forward on the global stage

Why Choose?

Dr. Viraj Lavingia

Highly qualified and experienced medical oncologist based in Ahmedabad, Gujarat.

Completed multiple certification courses including UICC (ICRETT) fellow at City of Hope, USA, ESMO certified, and ASCO in training exam.

Renowned specialist in multidisciplinary treatment of GI malignancies, particularly CRC.

Know

More About Treatments

Call Now
Call Now